SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System
Article
[키워드] activity
acute respiratory syndrome
adefovir dipivoxil
calculated
candidate
caused
Cell
Cepharanthine
conserved
coronavirus
Coronavirus infection
Coronavirus infections
COVID-19
COVID-19 pandemic
double-stranded RNA
drugs
effective
emtricitabine
entecavir hydrate
expression
immunofluorescence
inhibiting
inhibitors
Luminescence
lycorine
MERS-CoV
moroxydine
nucleotide
Plasmid
platform
Prophylactic
provide
RdRP
reliability
Remdesivir
replicated
reported
reporter plasmid
reproducibility
rifampin
RNA-dependent RNA polymerase
SARS-CoV-2
SARS-CoV-2 RdRp
SARS-CoV-2 RdRp inhibitor
screened
staining
System
telbivudine
therapeutic
therapeutic drug
Therapeutics
this system
viral RNA genome
Z-factor
[DOI] 10.3390/biomedicines9080996 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/biomedicines9080996 PMC 바로가기 [Article Type] Article